Releases

20170 items in section

Investors Scrutinize PicS N.V. Following IPO Disclosures

With an August 4, 2026, deadline approaching, shareholders who purchased PicS N.V. stock following the company's January IPO are weighing a class action lawsuit. Schall, Brown & Schwartz LLP is currently organizing the litigation, targeting alleged violations of federal securities laws stemming from misrepresented credit evaluation procedures.

BitGo Faces Class Action Lawsuit Over Alleged IPO Misstatements

Investors who purchased BitGo Holdings, Inc. stock following its January 2026 initial public offering face a critical window to join a securities fraud class action. Schall, Brown & Schwartz LLP is currently seeking lead plaintiffs for the lawsuit, which alleges the company misled the market regarding digital asset risks.

IMPACT Therapeutics Taps Pharmanovia for Global Senaparib Expansion

With a deal worth up to 423.5 million euros, Shanghai-based IMPACT Therapeutics has granted Pharmanovia exclusive rights to develop and distribute its PARP inhibitor, senaparib, across 66 countries. The partnership marks the biotech firm's first major strategic push to bring its oncology portfolio to markets outside of China.

Schall, Brown & Schwartz Launches Investigation into Seer, Inc.

Investors who incurred financial losses holding Seer, Inc. stock are now under scrutiny by the national litigation firm Schall, Brown & Schwartz. The legal group has opened a formal investigation into potential securities law violations, specifically examining whether the company released misleading information or suppressed data critical to its shareholders.

Investors Launch Class Action Against Wix Over Misleading AI Claims

A class action lawsuit alleges Wix.com Ltd. deceived shareholders by inflating the capabilities of its AI tools while obscuring the true costs of development. The litigation, filed in Los Angeles, targets statements made by the company between February 19, 2025, and May 12, 2026, regarding its competitive market standing.

Investors Targeted in Wix.com Securities Class Action Lawsuit

Investors who held Wix.com Ltd. stock between February 19, 2025, and May 12, 2026, face a critical deadline of September 22, 2026, to join a class action lawsuit. Schall, Brown & Schwartz LLP is currently seeking lead plaintiffs to represent those who suffered financial losses due to the company's alleged market misconduct.

Investors in GSFTX Face Potential Securities Claims Investigation

A national shareholder rights firm, Schall, Brown & Schwartz LLP, has launched an investigation into the Columbia Dividend Income Fund, traded as GSFTX. The inquiry centers on allegations that the fund issued misleading statements or withheld critical financial information from its investors, potentially violating federal securities laws.

GeneDx Faces Securities Class Action Over Alleged Misleading Financials

Investors who purchased GeneDx Holdings Corp. stock between April 16, 2025, and May 4, 2026, face an August 3, 2026, deadline to join a class action lawsuit. The litigation alleges the company violated the Securities Exchange Act by issuing false statements regarding its financial health and earnings outlook.

Hub Group Faces Class Action Lawsuit Over Financial Misstatements

Investors who purchased Hub Group, Inc. stock between April 28, 2023, and May 11, 2026, are being urged to join a class action lawsuit. The complaint alleges that the logistics firm misled the market by filing financial statements containing material errors regarding revenue recognition and operating income.

Investors Target PROCEPT BioRobotics Over Alleged Revenue Inflation

Shareholders of PROCEPT BioRobotics face a potential recovery path following a class action lawsuit alleging the company misled investors through aggressive accounting practices. The litigation focuses on claims that the firm artificially inflated revenue figures by pulling sales forward, creating a significant inventory glut between 2024 and 2026.

Investors Urged to Join Securities Fraud Class Action Against Hub Group

Investors who purchased Hub Group, Inc. securities between April 28, 2023, and May 11, 2026, face an August 28, 2026, deadline to seek lead plaintiff status in a pending class action lawsuit. The litigation targets alleged violations of the Securities Exchange Act, specifically regarding misleading financial disclosures.

Photronics Faces Securities Class Action Over Alleged Misleading Forecasts

Investors who purchased Photronics, Inc. shares between December 10, 2025, and May 27, 2026, face a critical window to join a class action lawsuit. The DJS Law Group is currently organizing the case, which centers on allegations that the company issued false statements regarding its product pipeline and financial momentum.

Investors Face September Deadline in Planet Fitness Securities Lawsuit

Investors who purchased Planet Fitness, Inc. common stock between November 6, 2025, and May 6, 2026, have until September 14, 2026, to file as lead plaintiffs in a pending securities fraud class action. The lawsuit alleges the company misled shareholders regarding its marketing efficacy and core customer acquisition metrics.

IMPACT Therapeutics Taps Pharmanovia for Global Senaparib Rollout

Shanghai-based IMPACT Therapeutics has secured an exclusive licensing deal with Pharmanovia to distribute its PARP inhibitor, senaparib, across 66 countries. The partnership targets maintenance therapy for advanced ovarian, fallopian tube, and primary peritoneal cancers, marking the biotech firm's first major commercial expansion beyond the Chinese market.

Investors Weigh Legal Action Against Erasca Over Drug Data Disclosures

Shareholders who acquired Erasca, Inc. stock between January 14, 2025, and April 26, 2026, face an August 10 deadline to join a class action lawsuit. The litigation, spearheaded by Schall, Brown & Schwartz LLP, alleges the company misled the market regarding the clinical viability of its ERAS-0015 drug candidate.

Roblox Faces Class Action Lawsuit Over Age Verification Disclosures

Investors who purchased Roblox Corporation shares between October 30, 2025, and April 30, 2026, are being urged to join a class action lawsuit. The litigation targets the gaming giant for allegedly misleading the market regarding the financial impact of its age verification policies on long-term growth.

ADMA Biologics Faces Securities Class Action Over Alleged Misconduct

Investors who purchased ADMA Biologics shares between August 9, 2024, and March 25, 2026, face a critical August 10, 2026, deadline to seek lead plaintiff status in a class action lawsuit. The litigation, filed by Schall, Brown & Schwartz LLP, targets alleged violations of the Securities Exchange Act of 1934.

Hanon Systems Returns to Profitability Amid Global Restructuring

Hanon Systems reported a second-quarter operating profit of KRW 103.7 billion, signaling a recovery driven by structural cost-cutting and a surge in electrification demand. The automotive thermal management supplier, now a subsidiary of Hankook & Company Group, posted quarterly revenue of KRW 2.87 trillion, stabilizing its financial position after recent global shifts.

Investors Urged to Join Securities Fraud Class Action Against GRAIL

With an August 4 deadline approaching, the law firm Schall, Brown & Schwartz is calling on shareholders who purchased GRAIL, Inc. stock between May 2025 and February 2026 to come forward. The move follows a class action complaint alleging the company misled the market regarding its high-profile NHS-Galleri cancer trial.

Investors Target PicS N.V. Over IPO Disclosure Failures

Investors who purchased PicS N.V. shares following the company’s January 30, 2026, initial public offering face an August 4 deadline to join a class action lawsuit. The litigation alleges the firm misled shareholders by misrepresenting the strength of its underwriting practices and credit evaluation procedures during its market debut.

Hanon Systems Expands ESG Governance with 2026 Steering Committee Plan

Hanon Systems, the global automotive thermal management specialist, has released the English translation of its 2025/26 ESG Report. The document outlines the company’s strategic shift toward electrification and Software-Defined Vehicles, while signaling a structural overhaul of its internal oversight mechanisms slated for the second half of next year.

Black Rock Coffee Faces Securities Class Action Over Store Expansion

Investors who purchased Black Rock Coffee Bar, Inc. stock between September 12, 2025, and May 12, 2026, face a critical deadline as a securities class action lawsuit moves forward. The DJS Law Group is currently organizing shareholders to address allegations that the company misled the market regarding its expansion strategy.

Robo.ai Names Dr. Jasem Al-Mansory CEO of Abu Dhabi-Based Alif Holding

With the appointment of Dr. Jasem Ibrahim Mansour Al-Mansory as Chief Executive Officer of Alif Holding, Robo.ai has finalized the core leadership team for its new Abu Dhabi-based industrial technology subsidiary. The move formalizes the governance structure for a group aimed at integrating AI systems across critical regional sectors.

Via Transportation Faces Class Action Over IPO Disclosures

Investors who purchased Via Transportation, Inc. stock following its September 2025 initial public offering now have until August 10, 2026, to join a class action lawsuit. The litigation alleges the company misled shareholders regarding the viability of its expansion strategy within the German market.

Embecta Shareholders Face August Deadline in Securities Fraud Action

Investors who purchased Embecta Corp. stock between November 25, 2025, and May 4, 2026, have until August 17 to participate in a class action lawsuit. The litigation, spearheaded by Schall, Brown & Schwartz LLP, alleges the company misled the market regarding its fiscal performance and financial guidance.

Roblox Faces Securities Fraud Class Action Over Growth Claims

Investors who purchased Roblox Corporation stock between October 30, 2025, and April 30, 2026, are being urged to join a class action lawsuit against the gaming company. Schall, Brown & Schwartz LLP is seeking lead plaintiffs for the action, which alleges the company misled the market regarding its business performance.

First Solar Faces Securities Class Action Over Alleged Misleading Claims

Investors who purchased First Solar shares between February 26, 2025, and February 24, 2026, are now under notice of a class action lawsuit. The litigation targets alleged violations of the Securities Exchange Act, centered on claims that the company misled the market regarding its operational transition from Asia to the United States.

Erasca Faces Securities Class Action Over Misleading Drug Claims

Investors who purchased Erasca, Inc. shares between January 14, 2025, and April 26, 2026, are being urged to join a class action lawsuit. The litigation alleges the company misled the market regarding the development and patent risks associated with its ERAS-0015 therapeutic candidate.